PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis - Canonica, G.W.; Blasi, F.; Crimi, N.; Paggiaro, P.; Papi, A.; Fanelli, F.; Stassaldi, A.; Serra, A.; Furneri, G. (Value in health, 2020)